These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

538 related items for PubMed ID: 7514249

  • 1. Growth analysis of marrow CD34-positive hematopoietic progenitor cells in patients with myelodysplastic syndromes.
    Asano H, Hotta T, Ichihara M, Murate T, Kobayashi M, Saito H.
    Leukemia; 1994 May; 8(5):833-8. PubMed ID: 7514249
    [Abstract] [Full Text] [Related]

  • 2. Interleukin-11 stimulates the proliferation of human hematopoietic CD34+ and CD34+CD33-DR- cells and synergizes with stem cell factor, interleukin-3, and granulocyte-macrophage colony-stimulating factor.
    Lemoli RM, Fogli M, Fortuna A, Motta MR, Rizzi S, Benini C, Tura S.
    Exp Hematol; 1993 Dec; 21(13):1668-72. PubMed ID: 7694867
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Mast cell growth factor (c-kit ligand) restores growth of multipotent progenitors in myelodysplastic syndrome.
    Glinsmann-Gibson B, Spier C, Baier M, Taetle R, Broudy VC, List AF.
    Leukemia; 1994 May; 8(5):827-32. PubMed ID: 7514248
    [Abstract] [Full Text] [Related]

  • 5. Effect of recombinant human stem cell factor on mafosfamide-treated bone marrow clonogenic cells.
    Carlo-Stella C, Mangoni L, Almici C, Caramatti C, Rizzoli V.
    Stem Cells; 1993 Jul; 11 Suppl 2():170-4. PubMed ID: 7691323
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Role of cytokines in leukemic type growth of myelodysplastic CD34+ cells.
    Sawada K, Ieko M, Notoya A, Tarumi T, Koizumi K, Kitayama S, Nishio H, Fukada Y, Yasukouchi T, Yamaguchi M, Katoh S, Koike T.
    Blood; 1996 Jul 01; 88(1):319-27. PubMed ID: 8704190
    [Abstract] [Full Text] [Related]

  • 8. Refractory cytopenia with multilineage dysplasia: further characterization of an 'unclassifiable' myelodysplastic syndrome.
    Rosati S, Mick R, Xu F, Stonys E, Le Beau MM, Larson R, Vardiman JW.
    Leukemia; 1996 Jan 01; 10(1):20-6. PubMed ID: 8558932
    [Abstract] [Full Text] [Related]

  • 9. Differential responses of myeloid progenitor cells from patients with myeloid leukemia and myelodysplasia to the costimulating effects of steel factor in vitro.
    Maze R, Horie M, Hendrie P, Vadhan-Raj S, Tricot G, Gordon M, Nemunaitis J, Ashman LK, Broxmeyer HE.
    Exp Hematol; 1993 Apr 01; 21(4):545-51. PubMed ID: 7681784
    [Abstract] [Full Text] [Related]

  • 10. Stem cell factor improvement of proliferation and maintenance of hemopoietic progenitors in myelodysplastic syndromes.
    Piacibello W, Sanavio F, Bresso P, Severino A, Carlesso N, Pregno P, Stacchini A, Morelli S, Fubini L, Gallo E.
    Leukemia; 1994 Feb 01; 8(2):250-7. PubMed ID: 7508532
    [Abstract] [Full Text] [Related]

  • 11. Effect of stem cell factor (c-kit ligand), granulocyte-macrophage colony stimulating factor and interleukin 3 on hematopoietic progenitors in human long-term bone marrow cultures.
    Lemoli RM, Gulati SC.
    Stem Cells; 1993 Sep 01; 11(5):435-44. PubMed ID: 7694721
    [Abstract] [Full Text] [Related]

  • 12. Proliferation and differentiation of myelodysplastic CD34+ cells in serum-free medium: response to individual colony-stimulating factors.
    Sawada K, Sato N, Tarumi T, Sakai N, Koizumi K, Sakurama S, Ieko M, Yasukouchi T, Koyanagawa Y, Yamaguchi M.
    Br J Haematol; 1993 Mar 01; 83(3):349-58. PubMed ID: 7683482
    [Abstract] [Full Text] [Related]

  • 13. Evaluation of the in vitro behavior of phenotypically defined populations of umbilical cord blood hematopoietic progenitor cells.
    Traycoff CM, Abboud MR, Laver J, Brandt JE, Hoffman R, Law P, Ishizawa L, Srour EF.
    Exp Hematol; 1994 Feb 01; 22(2):215-22. PubMed ID: 7507862
    [Abstract] [Full Text] [Related]

  • 14. Blast colony-forming cells in myelodysplastic syndrome: decreased potential to generate erythroid precursors.
    Backx B, Broeders L, Touw I, Löwenberg B.
    Leukemia; 1993 Jan 01; 7(1):75-9. PubMed ID: 8418382
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Proliferation and differentiation of myelodysplastic CD34+ cells: phenotypic subpopulations of marrow CD34+ cells.
    Sawada K, Sato N, Notoya A, Tarumi T, Hirayama S, Takano H, Koizumi K, Yasukouchi T, Yamaguchi M, Koike T.
    Blood; 1995 Jan 01; 85(1):194-202. PubMed ID: 7528567
    [Abstract] [Full Text] [Related]

  • 17. Recombinant human mast cell growth factor supports erythroid colony formation in polycythemia vera in the presence and absence of erythropoietin and serum.
    Muller EW, de Wolf JT, Hendriks DW, Esselink MT, Halie MR, Vellenga E.
    Exp Hematol; 1993 Sep 01; 21(10):1353-7. PubMed ID: 7689483
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The effect of stem-cell factor, interleukin-3 and erythropoietin on in vitro erythropoiesis in myelodysplastic syndromes.
    Verbeek W, Vehmeyer K, Wörmann B, Hiddemann W.
    J Cancer Res Clin Oncol; 1995 Sep 01; 121(6):338-42. PubMed ID: 7797598
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.